A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.
about
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genesInduction of human epithelial stem/progenitor expansion by FOXM1The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube originFunctional characterisation of the WW minimal domain for delivering therapeutic proteins by adenovirus dodecahedronStructure of the FoxM1 DNA-recognition domain bound to a promoter sequenceFOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathwaysFOXM1, a typical proliferation-associated transcription factorPeroxiredoxin 3 is a redox-dependent target of thiostrepton in malignant mesothelioma cellsPostnatal development, maturation and aging in the mouse cochlea and their effects on hair cell regeneration.Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis.FoxM1 is a general target for proteasome inhibitors.Ufm1 inhibits LPS-induced endothelial cell inflammatory responses through the NF-κB signaling pathway.Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.FoxM1 mediates resistance to herceptin and paclitaxel.Pro-proliferative FoxM1 is a target of p53-mediated repression.CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.FoxM1 is a downstream target and marker of HER2 overexpression in breast cancerThe forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsIdentification of candidate B-lymphoma genes by cross-species gene expression profiling.Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models.Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis.The ufm1 cascade.Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia.Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts.Basal cell carcinomas: attack of the hedgehog.The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNADeregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesisEssential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.Deregulation of FoxM1b leads to tumour metastasis.FoxM1 and Wnt/β-catenin signaling in glioma stem cells.Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling.High-dimensional biology to comprehend hepatocellular carcinoma.Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells.3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis.Forkhead box M1 transcriptional factor is required for smooth muscle cells during embryonic development of blood vessels and esophagus.
P2860
Q24314901-9AC80A7D-CC70-4CAB-BB11-9ABF1C27FD9BQ24615565-EFF28448-986B-40B3-9E99-E1218B3305A1Q27008375-6AA69E8C-61CD-4660-905C-4BF4996B69F0Q27318180-CFC1FCD1-DF81-4394-BCFF-0E7CF60975A0Q27660395-FC1770C4-BC8A-4DC8-BD80-0CD11653173CQ28076296-C0D9F938-B2E1-4EB6-AD90-7EA5AC23CFD5Q28257808-938FA50C-7C6A-42D9-8C1D-0C371733AFAAQ28728015-057DF8E9-F50C-46B0-8A3F-8517AC39BD2EQ30442295-70C0C331-42DD-45F8-A42A-A04E8C2E1081Q33318574-AC13921F-8131-472F-BEF3-3DB3491D58F6Q33492769-BDD5553B-7F9E-42BE-A328-81C4757F5BC9Q33492774-2FEA7665-3414-48DA-967C-4649C9DC1643Q33598824-3119C263-C404-4182-92F6-9D6CE2CE1127Q33647335-37F7DAF4-2C22-4D16-AD33-D850CC6A34B4Q33762091-8F03F098-777D-4C86-AF04-1F8227DD7400Q33864523-652D64B3-62B2-425B-A3BF-7FF53AADBB69Q33904328-8A410CEF-97F8-4B6C-A9FE-0B6FFBA75E62Q33946664-CDD964F2-AE89-4F9B-9A23-792735D894F0Q33966216-C3D1FD64-2433-4A1C-8BE8-0184ECDF9ABFQ34364651-A69D7BA7-A416-4DF1-819E-3769BCCF0D67Q34725700-07B8FFFA-39F4-4417-94E1-B30784989ED5Q35000256-CD2B891D-10F4-4DF1-8E5C-E06C078C328EQ35018604-509DC073-E55F-4254-A2B4-AF8A5CE491B8Q35045311-87F779C1-7C49-40F1-BBA5-AD39172D16A7Q35073171-0D2F6490-6A13-4B69-9A24-842BDB1E10BBQ35185917-50BE0721-F4E9-43A0-BE46-8B7980F62A18Q35197045-80C02A8E-DE2D-41C7-9503-83AC4DF2BE03Q35613017-7108F438-35BB-4084-8FE8-62C46367AF12Q35687900-72CC1B4B-D351-4DF7-85F3-F8C67F168D57Q35764362-8777020B-A458-4F0B-8B97-4D76C4EB6117Q35818801-9DD15B02-9F95-49C3-9906-A637CC9AED77Q35868092-4F7BD6A9-72AA-4807-B106-A3E5D706465EQ36108360-D8E5D715-D048-453F-A13C-809EFAD84866Q36405760-C0C53792-9812-4724-87A4-24BD736FF98BQ36590628-FD50F0E6-21E1-49A4-9F46-4487C531EB4DQ37087376-6EF3FC1F-1541-470E-8870-3A47780CB587Q37144678-231D28F1-2E24-47C0-AC7E-4F466A5B20A2Q37243057-634E77E4-6B9D-4789-B928-60F71D608045Q37311904-8EBD56F2-15A6-4171-97E7-771ECBEFBB2FQ37439122-67A888B4-47F3-40DB-A5D3-7D994B82FFCC
P2860
A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@ast
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@en
type
label
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@ast
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@en
prefLabel
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@ast
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@en
P2093
P2860
P356
P1476
A cell-penetrating ARF peptide ...... ocellular carcinoma treatment.
@en
P2093
Galina A Gusarova
I-Ching Wang
Michael L Major
Robert H Costa
Timothy Ackerson
Vladimir Petrovic
Vladimir V Kalinichenko
P2860
P304
P356
10.1172/JCI27527
P407
P577
2006-12-14T00:00:00Z